Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?

Autoimmun Rev. 2021 Jun;20(6):102824. doi: 10.1016/j.autrev.2021.102824. Epub 2021 Apr 20.

Authors

Philippe Mertz¹, Juliette Jeannel², Aurélien Guffroy³, Sylvain Lescuyer², Anne Sophie Korganow³, Murielle Rondeau-Lutz², Jean Christophe Weber²

Affiliations

¹ Internal Medicine department, Strasbourg University Hospital, Strasbourg, France. Electronic address: philippe.mertz@chru-strasbourg.fr.
² Internal Medicine department, Strasbourg University Hospital, Strasbourg, France.
³ Clinical Immunology department, National Reference Center for Rare Autoimmune Diseases (RESO), ERN RITA, Strasbourg University Hospital, Strasbourg, France.

No abstract available

Keywords: Angiotensin-converting enzyme II; COVID19; Granulomatous disease; Mucosal associated invariant T cells; Sarcoidosis.

Publication types

Letter

MeSH terms

COVID-19*
Humans
Peptidyl-Dipeptidase A
SARS-CoV-2
Sarcoidosis*

Substances

Peptidyl-Dipeptidase A